To hear about similar clinical trials, please enter your email below
Trial Title:
Specimen Banking From Patients With Lung Cancer
NCT ID:
NCT01585675
Condition:
Lung Neoplasms
Conditions: Official terms:
Lung Neoplasms
Conditions: Keywords:
Lung Cancer
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
The primary objective of the protocol is to develop a comprehensive specimen banking
program from patients with lung cancer for future translation research, which will enable
the investigators to detect lung cancer earlier, develop better therapies and explore
screening and prevention strategies.
Detailed description:
The aims of the study are as follows: 1) to continue to unravel the complex biology of
lung cancer 2) to identify early detection and prognostic markers to guide therapeutic
decision 3) to define markers of response and/or resistance to drug therapy, and 4) to
identify new therapeutic and prevention targets.
Criteria for eligibility:
Study pop:
Subjects who are undergoing further testing for the diagnosis or treatment of lung
cancer.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
1. Subjects who are undergoing further testing for the diagnosis or treatment of lung
cancer.
2. Oral and written informed consent
Exclusion Criteria:
1. Any individual who does not give oral and written consent for participation
Gender:
All
Minimum age:
18 Years
Maximum age:
85 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
University of Colorado Cancer Center
Address:
City:
Aurora
Zip:
80045
Country:
United States
Status:
Recruiting
Contact:
Last name:
Brandi Kubala
Phone:
303-724-1657
Email:
brandi.kubala@cuanschutz.edu
Investigator:
Last name:
Adriaan VanBokhoven, PhD
Email:
Principal Investigator
Start date:
November 3, 2005
Completion date:
July 1, 2035
Lead sponsor:
Agency:
University of Colorado, Denver
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
University of Colorado, Denver
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01585675
